XLON
THRL
Market cap927mUSD
Oct 09, Last price
112.20GBP
1D
-0.18%
1Q
1.45%
Jan 2017
-0.71%
IPO
9.46%
Name
Target Healthcare REIT PLC
Chart & performance
P/E
8.43
P/S
9.66
EPS
0.13
Div yield, %
5.24%
Shrs. gr., 5y
5.46%
Rev. gr., 5y
7.59%
Revenues
72m
-1.18%
Net income
83m
+35.74%
CFO
45m
+8.93%
Dividend
Aug 13, 20261.508 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Target Healthcare REIT offers specialized financial solutions, custom-designed to assist operators in expanding the availability of modern, purpose-built residential care facilities throughout the United Kingdom.
Related entities
Subsidiaries (5)
TARGET HEALTHCARE REIT LIMITED
THR NUMBER 12 PLC
THR NUMBER 43 PLC
THR NUMBER 15 PLC
THR NUMBER ONE PLC
Key people
Kenneth Mackenzie
Chief Executive, Founder
Gordon Bland
Finance Director
Andrew Brown
Head - Healthcare
John Flannelly
Head - Investment
Scott Steven
Head - Asset Management
Donald Cameron
Company Secretary, Director - Financial Reporting
Alison Fyfe
Independent Non-Executive Chairman of the Board · since 2022
Michael Brodtman
Independent Non-Executive Director · since 2023
Senior Independent Non-Executive Director · since 2022
Independent Non-Executive Director · since 2021
Amanda Thompsell
Independent Non-Executive Director · since 2022
IPO date
Mar 07, 2013
Employees
0
Domiciled in
GB
Incorporated in
GB
Legal address
LEVEL 4, DASHWOOD HOUSE
69 OLD BROAD STREET
LONDON, LND EC2M 1QS
GB
69 OLD BROAD STREET
LONDON, LND EC2M 1QS
GB
Headquarters
C/O TARGET FUND MANAGERS LIMITED
GLENDEVON HOUSE
CASTLE BUSINESS PARK
STIRLING, STG FK9 4TZ
GB
GLENDEVON HOUSE
CASTLE BUSINESS PARK
STIRLING, STG FK9 4TZ
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||